GHXIU

GHXIU

CIK 0002086438

Small by assets Assets $360M as of Sep 6, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (WLTH 10-Q) is open in full — no account needed.

8-K Filed Aug 6, 2026 · Period ending Aug 6, 2026

Summary not yet generated.

10-Q Filed Jul 24, 2026 · Period ending Jun 30, 2026

Summary not yet generated.

Partner

Trade GHXIU commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed Jun 30, 2026 · Period ending Jun 24, 2026

Summary not yet generated.

8-K Filed Jun 24, 2026 · Period ending Jun 22, 2026

Summary not yet generated.

424B4 Filed Jun 23, 2026 Red flag

GHXIU, a blank-check company, prices 31.2M units at $10.00 each, raising $312M for a future business combination

7 material changes detected. Sign up free to read the summary.

S-1 Filed Jun 3, 2026

Summary not yet generated.

Latest financial statements

From 10-Q filed Jul 24, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Condensed Statements of Operations (Unaudited)

Description Three months ended June 30, 2026 Six months ended June 30, 2026
Professional fees and other expenses (124,716) (124,716)
Net loss from operations (124,716) (124,716)
Change in fair value of public warrant liabilities (717,600) (717,600)
Allocated expense for warrant issuance cost (270,678) (270,678)
Other income interest income from Trust Account 207,092 207,092
Net loss (905,902) (905,902)
Net loss per ordinary share:
Basic and diluted weighted average shares outstanding of Class A redeemable ordinary shares 2,760,000 1,387,624
Basic and diluted net loss per share, Class A redeemable ordinary shares (2.58) (2.98)
Basic and diluted weighted average shares outstanding of Class A non-redeemable ordinary shares 17,308 8,702
Basic and diluted net loss per share, Class A non-redeemable ordinary shares (2.58) (2.98)
Basic and diluted weighted average shares outstanding, Class B ordinary shares(1) 7,890,000 7,845,249
Basic and diluted net loss per share, Class B ordinary shares (2.58) (2.98)

Condensed Balance Sheets

Description June 30, 2026 (unaudited) June 30, 2026 December 31, 2025
ASSETS:
Current assets:
Cash 1,123,701
Deferred offering costs associated with public offering 461,784
Total current assets 1,123,701 461,784
Investments held in Trust Account 359,007,092
Total assets 360,130,793 461,784
LIABILITIES AND SHAREHOLDERS' DEFICIT
Current liabilities:
Accrued expenses, formation and offering costs 53,856 418,946
Notes payable related party 69,793
Total current liabilities: 53,856 488,739
Public warrants derivative liability 5,023,200
Advisory fee 10,764,000
Deferred underwriting compensation 10,764,000
Total liabilities 26,605,056 488,739
Commitments and contingencies
Class A ordinary shares subject to possible redemption, 35,880,000 and -0- shares, respectively (at redemption value of $10.00 and $0.00 per share at June 30, 2026 and December 31, 2025, respectively) 358,800,000
Shareholders' deficit:
Preferred shares, $0.0001 par value; 1,000,000 shares authorized, none issued or outstanding, at June 30, 2026 and December 31, 2025, respectively
Ordinary shares
Class A ordinary shares, $0.0001 par value; 400,000,000 shares authorized, 225,000 and -0- shares, respectively, issued and outstanding, excluding 35,880,000 and -0- shares at June 30, 2026 and December 31, 2025, respectively, subject to possible redemption 23
Class B ordinary shares, $0.0001 par value, 40,000,000 shares authorized; 8,970,000 shares issued and outstanding, at June 30, 2026 and December 31, 2025, respectively(1) 897 897
Additional paid-in capital 24,103
Accumulated deficit (25,275,183) (51,955)
Total shareholders' deficit (25,274,263) (26,955)
Total liabilities and shareholders' deficit 360,130,793 461,784

Condensed Statement of Cash Flows (Unaudited)

Description Six months ended June 30, 2026
Net loss (905,902)
Adjustments to reconcile net loss to net cash used in operating activities
Allocated expense for warrant issuance cost 270,678
Interest income from trust account (207,092)
Gain from change in fair value of public warrant liabilities 717,600
Changes in operating assets and liabilities:
Accrued expenses, formation and offering costs (365,090)
Net cash used in operating activities (489,806)
Cash flows from investing activities:
Cash deposited in Trust Account (358,800,000)
Net cash used in investing activities (358,800,000)
Cash flows from financing activities:
Proceeds from sale of Units in initial public offering 358,800,000
Proceeds from sale of Private Placement Shares to Sponsor 2,250,000
Payment of accrued offering costs (316,700)
Payment of underwriter's discounts and commissions (250,000)
Proceeds from notes payable related party 166,327
Repayment of notes payable related party (236,120)
Net cash provided by financing activities 360,413,507
Net change in cash 1,123,701
Cash at beginning of period
Cash at end of period 1,123,701
Supplemental disclosure of non-cash financing activities:
Offering costs included in accrued expenses, formation and offering costs 30,061
Advisory fee 10,764,000
Deferred underwriting compensation 10,764,000
Offering costs charged to additional paid in capital 1,028,484
Initial classification of warrant liability public 4,305,600

Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗